Neurent Medical, a fast-growing Irish innovator in ENT healthcare, has opened a state-of-the-art manufacturing facility in Oranmore, set to create 125 highly skilled jobs by 2028. The facility will centralise production of NEUROMARK®, its FDA-cleared, minimally invasive solution for chronic rhinitis, supporting rapid US market expansion.

This is a strategic play in MedTech manufacturing, IP control, and international distribution from a regional base. It also highlights the strength of Ireland’s innovation pipeline, with Neurent emerging from the BioInnovate Ireland Programme to become a global player in under a decade.

As the sector continues shifting towards specialist, precision-based treatments, partnerships like Neurent’s—with academic institutions, government, and Enterprise Ireland—show how R&D-driven growth can anchor world-class manufacturing closer to home.

See how Irish-engineered MedTech is shaping the global ENT market—read the full article.